News
Recent News
11/30/2023
ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs
ATCC, the world’s premier biological materials management and standards organization, today announced a seven-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to continue the management of the BEI Resources Program. NIAID has made an initial award of over $21.5 million, with further funding …
11/30/2023
Acclinate Collaborates with Merck to Increase Clinical Trial Diversity
Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the United States and Canada, to help increase participation by members of the Black/African American community in Merck’s oncology clinical studies. “We’re proud to be working with Merck because being a champion for health equity through inclusive research …
11/27/2023
cultivate(MD) Capital Funds LP Announces Investment into Nanochon
cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that they have made a significant investment into Nanochon, a Washington, D.C.—based regenerative cartilage innovator. Nanochon develops solutions utilized by sports medicine physicians to treat active patients requiring cartilage restoration. Nanochon’s Chondrograft™ replaces lost or damaged …